Purpose The aim of this study was to evaluate the impact of the COVID-19 lockdown occurred in Italy from March 9th to May 18th, 2020 on anthropometric parameters and glycemic control in patients with type 2 diabetes mellitus (T2DM). Methods One hundred twenty-eight consecutive patients with T2DM (median age 70 years, 74 males) were retrospectively evaluated at the end of the lockdown period. Data on metabolic control were collected at different time: within three months before the lockdown (visit 0) and within the first six weeks after it (visit 1). Results During the lockdown, a significant increase in body weight (from 79.7 +/- 18.7 kg to 81.4 +/- 19.4 kg, p < 0.001), body mass index (BMI, from 29.5 +/- 6 kg/m(2) to 30.1 +/- 6.3 kg/m(2), p < 0.001), waist circumference (from 103.8 +/- 13 cm to 105 +/- 13.6 cm, p < 0.001), fasting plasma glucose (FPG; from 138.1 +/- 29.4 mg/dL to 146.6 +/- 36.4 mg/dL) and glycated hemoglobin (HbA1c; from 7 +/- 0.8 to 7.3 +/- 0.9%, p < 0.001) was observed. Weight gain was directly associated with HbA1c increase (beta 0.085, C.I. 95% 0.05-0.121; p < 0.001) while insulin therapy resulted to be the only significant independent predictor of HbA1c worsening at the multivariate logistic regression analysis (OR 2.40, C.I. 1.06-5.45; p = 0.035). Conclusions The lockdown due to COVID-19 pandemic had a negative impact on body weight and glucose control in T2DM patients, in particular in those on insulin treatment. This finding provides a further rationale to optimize the diabetes management during eventually new period of home confinement.

Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect

Lania, Andrea Gerardo;Mazziotti, Gherardo;
2021-01-01

Abstract

Purpose The aim of this study was to evaluate the impact of the COVID-19 lockdown occurred in Italy from March 9th to May 18th, 2020 on anthropometric parameters and glycemic control in patients with type 2 diabetes mellitus (T2DM). Methods One hundred twenty-eight consecutive patients with T2DM (median age 70 years, 74 males) were retrospectively evaluated at the end of the lockdown period. Data on metabolic control were collected at different time: within three months before the lockdown (visit 0) and within the first six weeks after it (visit 1). Results During the lockdown, a significant increase in body weight (from 79.7 +/- 18.7 kg to 81.4 +/- 19.4 kg, p < 0.001), body mass index (BMI, from 29.5 +/- 6 kg/m(2) to 30.1 +/- 6.3 kg/m(2), p < 0.001), waist circumference (from 103.8 +/- 13 cm to 105 +/- 13.6 cm, p < 0.001), fasting plasma glucose (FPG; from 138.1 +/- 29.4 mg/dL to 146.6 +/- 36.4 mg/dL) and glycated hemoglobin (HbA1c; from 7 +/- 0.8 to 7.3 +/- 0.9%, p < 0.001) was observed. Weight gain was directly associated with HbA1c increase (beta 0.085, C.I. 95% 0.05-0.121; p < 0.001) while insulin therapy resulted to be the only significant independent predictor of HbA1c worsening at the multivariate logistic regression analysis (OR 2.40, C.I. 1.06-5.45; p = 0.035). Conclusions The lockdown due to COVID-19 pandemic had a negative impact on body weight and glucose control in T2DM patients, in particular in those on insulin treatment. This finding provides a further rationale to optimize the diabetes management during eventually new period of home confinement.
2021
COVID-19
Glycemic control-lockdown
Type 2 diabetes mellitus
Weight change
Aged
Blood Glucose
Communicable Disease Control
Glycated Hemoglobin A
Glycemic Control
Humans
Italy
Male
Pandemics
Retrospective Studies
SARS-CoV-2
COVID-19
Diabetes Mellitus, Type 2
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/64508
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 56
  • ???jsp.display-item.citation.isi??? 52
social impact